- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01308593
Brow Enhancement Study
January 3, 2013 updated by: Derek H. Jones, M.D., Skin Care and Laser Physicians of Beverly Hills
Investigation Into Brow Aesthetics Using Botox in Conjunction With Juvederm Ultra XC as Evaluated by Patient Satisfaction
Investigation into brow aesthetics using Botox in Conjunction with Juvederm XC as evaluated by patient satisfaction
Study Overview
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90069
- Skin Care and Laser Physicians of Beverly Hills
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Men and women
Exclusion Criteria:
- Persons who have not had Botox for months.
- Women who are pregnant, breastfeeding, or trying to get pregnant.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Juvederm XC
|
Filler
|
Active Comparator: Botox
Medication used to block neuromuscular transmission
|
26 units dosed one time
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Participant satisfaction with combined injection with Botox and Juvederm XC
Time Frame: 5 months
|
5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (Actual)
October 1, 2011
Study Completion (Actual)
October 1, 2011
Study Registration Dates
First Submitted
March 2, 2011
First Submitted That Met QC Criteria
March 3, 2011
First Posted (Estimate)
March 4, 2011
Study Record Updates
Last Update Posted (Estimate)
January 4, 2013
Last Update Submitted That Met QC Criteria
January 3, 2013
Last Verified
January 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- Brow Study 25856/1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brow Ptosis
-
Kenneth BeerMedicis Pharmaceutical CorporationCompleted
-
The New York Eye & Ear InfirmaryCompleted
-
Eyelid and Facial ConsultantsOchsner Health SystemUnknownBrow Ptosis | Facial ScarringUnited States
-
Cody BlanchardRecruitingSurgical Wound | Brow PtosisUnited States
-
St Joseph University, Beirut, LebanonUnknown
-
Zift, LLCLibra MedicalTerminatedSenile PtosisUnited States
-
Meir Medical CenterUnknown
-
Maastricht University Medical CenterWithdrawn
-
Ain Shams UniversityCompletedMild Ptosis | Moderate PtosisEgypt
-
Sheba Medical CenterUnknownSurgical Procedure, Unspecified | Ptosis, Eyelid | Ptosis; Eyelid, CongenitalIsrael
Clinical Trials on Juvederm XC
-
AllerganCompletedModerate to Severe Nasolabial FoldsUnited States
-
Dongkook Pharmaceutical Co., Ltd.CompletedNasolabial FoldsKorea, Republic of
-
AllerganCompletedSubjects Desiring Lip AugmentationUnited States
-
DeNova ResearchCompleted
-
AllerganCompletedPatients With Moderate to Severe Perioral LinesUnited States
-
AllerganCompletedLip AugmentationUnited States
-
University of PennsylvaniaActive, not recruitingDermal Filler | RejuvenationUnited States
-
Schoenhaus, Jodi, DPMUnknownMetatarsalgia | Fat Pad Syndrome | Corns | Hyperkeratotic CallusUnited States
-
Kenneth BeerAllerganUnknownMandibular HypoplasiaUnited States
-
University of OklahomaACE Surgical Supply, Inc.CompletedOral Ridge PreservationUnited States